Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
2024 · Translational Oncology · 5 citations
https://doi.org/10.1016/j.tranon.2024.102224
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
11
Citations
2
h-index
0
i10-index
Yasmin Fede Melzer is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research. The author has an h-index of 2, co-authored 6 publications.
ORCID: 0009-0007-4199-1807Click to start Chat